Table 3.
Differences in relative importance of UTI treatment preferences between identified latent classes for each attribute and level
| Class 1 | Class 2 | Class 3 | |
| Class share (%) | 17 | 38 | 45 |
| Attribute levels | |||
| Treatment duration | |||
| 3 days (vs 1 day) | −0.24 (−0.54 to 0.07) | −0.30 (−0.54 to −0.07) | −0.28 (−0.48 to −0.09) |
| 5 days (vs 1 day) | −0.36 (−0.54 to −0.18) | −0.44 (−0.66 to −0.22) | −0.53 (−0.74 to −0.33) |
| Time to resolution | |||
| 4 days (vs 1 day) | −1.59 (−1.91 to −1.27) | −1.79 (−2.33 to −1.26) | −0.08 (−0.37 to 0.22) |
| 7 days (vs 1 day) | −2.46 (−2.75 to −2.17) | −6.09 (−6.79 to −5.40) | −0.78 (−1.01 to −0.55) |
| Complication risk (%) | −0.25 (−0.29 to −0.21) | −0.32 (−0.38 to −0.26) | −0.34 (−0.39 to −0.29) |
| Risk of side effects (%) | −0.20 (−0.24 to −0.16) | −0.29 (−0.35 to −0.23) | −0.28 (−0.33 to −0.23) |
| Increases resistance* (vs not) | 1.16 (0.96 to 1.36) | −2.28 (−2.53 to −2.05) | −3.02 (−3.26 to −2.78) |
| Class assignment model | |||
| Age (years) | 0.00 (−0.02 to 0.01) | −0.02 (−0.03 to 0.00) | 0.00 |
| Previous UTI | |||
| 1 (vs no) | 0.26 | 0.52 (0.07 to 0.98) | 0.00 |
| >1 (vs no) | 0.00 | −0.43 (−1.02 to 0.17) | 0.00 |
| Education (vs low/middle) | −0.68 | 0.28 (−0.19 to 0.75) | 0.00 |
Results of the latent-class conditional logit model.
Bold indicates significance at the 5% level.
Data are shown as coefficients (95% CI).
*Antimicrobial resistance.
UTI, urinary tract infection.